Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Internalizing RGD (iRGD)-modified liposomal nanoparticles as a universal antigen-delivering platform for remodeling tumors and enhancing T-cell receptor-engineered T cell immunotherapy.

T cell receptor-engineered T cell (TCR-T) therapy holds promise for solid tumors but faces challenges from insufficient and non-uniform antigen presentation and inefficient T-cell tumor delivery. Current strategies that rely on endogenous tumor antigen expression are often limited by transcriptional silencing or downre...

Hao-Yue Qi, Han-Xi Zhang, Chen-Xu Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.